Skip to main content
. 2024 Apr 9;46:e-rbgo33. doi: 10.61622/rbgo/2024rbgo33

Table 2. Gender affirming hormone tratment prescribed: route of administration and medical compounds.

Parameter n(%)
GAHT route of administration
Oral 47(54.7)
Parenteral 16(18.6)
Both 23(26.7)
Medical compound
Estrogen + cyproterone or spironolactone 39(45.3)
Estrogen+progestogen 17(19.8)
Estrogen only 30(34.9)

GAHT - gender affirming hormone treatment, values expressed in absolute number (percentages)